Most recently, Dr Becker served as senior director of small molecule development international at Biogen Idec, where he managed all chemistry, manufacturing and controls-related small molecule activities.
Dr Becker’s background also includes a broad range of senior management positions in R&D at Lilly Research Laboratories and Boehringer Ingelheim.
Gearoid Faherty, chairman and CEO of Eurand, said: “Robert is an important and welcome addition to Eurand’s global leadership team. His extensive experience in product development will help to fuel our continuing growth as a specialty pharmaceutical company focused on the gastroenterology market.”